Literature DB >> 11021677

A trial for comparing methods for eliciting treatment preferences from men with advanced prostate cancer: results from the initial visit.

J Souchek1, J R Stacks, B Brody, C M Ashton, R B Giesler, M M Byrne, K Cook, J M Geraci, N P Wray.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the convergent validity of 3 types of utility measures: standard gamble, time tradeoff, and rating scale. RESEARCH
DESIGN: A prospective cohort of 120 men with advanced prostate cancer were first asked to rank order 8 health states, and then utility values were obtained from each participant for each of the 8 health states through 2 of the 3 techniques evaluated (standard gamble, time tradeoff and rating scale). Participants were randomly assigned to 1 of 3 possible pairs of techniques. The validity of the 3 methods, as measured by the convergence and raw score differences of the techniques, was assessed with ANOVA. The ability of the techniques to differentiate health states was determined. The inconsistencies between rankings and utility values were also measured. Proportions of illogical utility responses were assessed as the percent of times when states with more symptoms were given higher or equal utility values than states with fewer symptoms.
RESULTS: There were significant differences in raw scores between techniques, but the values were correlated across health states. Utility values were often inconsistent with the rank order of health states. In addition, utility assessment did not differentiate the health states as well as the rank order. Furthermore, utility values were often illogical in that states with more symptoms received equal or higher utility values than states with fewer symptoms.
CONCLUSIONS: Use of the utility techniques in cost-effectiveness analysis and decision making has been widely recommended. The results of this study raise serious questions as to the validity and usefulness of the measures.

Entities:  

Mesh:

Year:  2000        PMID: 11021677     DOI: 10.1097/00005650-200010000-00008

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  9 in total

Review 1.  Methods for incorporating patients' views in health care.

Authors:  Michel Wensing; Glyn Elwyn
Journal:  BMJ       Date:  2003-04-19

2.  Can urban methadone patients complete health utility assessments?

Authors:  Paul A Teixeira; Bruce R Schackman
Journal:  Patient Educ Couns       Date:  2008-03-07

3.  Design and usability of heuristic-based deliberation tools for women facing amniocentesis.

Authors:  Marie-Anne Durand; Odette Wegwarth; Jacky Boivin; Glyn Elwyn
Journal:  Health Expect       Date:  2011-01-18       Impact factor: 3.377

4.  Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes.

Authors:  Mary E Tinetti; Gail J McAvay; Terri R Fried; Heather G Allore; Joanna C Salmon; Joanne M Foody; Luann Bianco; Sandra Ginter; Liana Fraenkel
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

5.  Research on patients' views in the evaluation and improvement of quality of care.

Authors:  M Wensing; G Elwyn
Journal:  Qual Saf Health Care       Date:  2002-06

6.  Inconsistency over time in the preferences of older persons with advanced illness for life-sustaining treatment.

Authors:  Terri R Fried; John O'Leary; Peter Van Ness; Liana Fraenkel
Journal:  J Am Geriatr Soc       Date:  2007-07       Impact factor: 5.562

7.  Incorporating patients' preferences into medical decision making.

Authors:  Liana Fraenkel
Journal:  Med Care Res Rev       Date:  2012-11-06       Impact factor: 3.929

8.  Changes in preferences for life-sustaining treatment among older persons with advanced illness.

Authors:  Terri R Fried; Peter H Van Ness; Amy L Byers; Virginia R Towle; John R O'Leary; Joel A Dubin
Journal:  J Gen Intern Med       Date:  2007-04       Impact factor: 5.128

9.  What are the essential elements to enable patient participation in medical decision making?

Authors:  Liana Fraenkel; Sarah McGraw
Journal:  J Gen Intern Med       Date:  2007-05       Impact factor: 5.128

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.